Herrmann et al, 2014 reported two mutations in the human syt2 gene implicated in the etiology of congenital myasthenic syndrome patients: the proline to leucine (sytP-L) mutation analyzed in this paper and an adjacent aspartate to alanine (sytD-A) mutation. This evidence concerns the gene SYT2 and Congenital myasthenic syndromes.